Swiss National Bank Sells 22,200 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

Swiss National Bank trimmed its position in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 3.2% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 677,400 shares of the company’s stock after selling 22,200 shares during the period. Swiss National Bank owned about 0.30% of Bath & Body Works worth $29,237,000 as of its most recent SEC filing.

Several other hedge funds also recently added to or reduced their stakes in BBWI. New York Life Investment Management LLC grew its stake in Bath & Body Works by 2.1% in the 4th quarter. New York Life Investment Management LLC now owns 57,546 shares of the company’s stock worth $2,484,000 after acquiring an additional 1,208 shares in the last quarter. South Dakota Investment Council boosted its stake in shares of Bath & Body Works by 4.5% during the fourth quarter. South Dakota Investment Council now owns 74,677 shares of the company’s stock valued at $3,223,000 after purchasing an additional 3,200 shares in the last quarter. GAMMA Investing LLC bought a new position in shares of Bath & Body Works during the fourth quarter valued at approximately $27,000. CWM LLC boosted its stake in shares of Bath & Body Works by 7.3% during the fourth quarter. CWM LLC now owns 5,167 shares of the company’s stock valued at $223,000 after purchasing an additional 353 shares in the last quarter. Finally, abrdn plc boosted its stake in shares of Bath & Body Works by 70.5% during the fourth quarter. abrdn plc now owns 96,346 shares of the company’s stock valued at $4,158,000 after purchasing an additional 39,846 shares in the last quarter. 95.14% of the stock is currently owned by institutional investors.

Bath & Body Works Stock Up 0.8 %

Shares of NYSE BBWI opened at $47.62 on Thursday. The company’s 50-day simple moving average is $46.08 and its 200-day simple moving average is $41.38. Bath & Body Works, Inc. has a 52-week low of $27.30 and a 52-week high of $50.34. The firm has a market cap of $10.71 billion, a price-to-earnings ratio of 12.37, a price-to-earnings-growth ratio of 1.49 and a beta of 1.89.

Bath & Body Works (NYSE:BBWI) last announced its earnings results on Thursday, February 29th. The company reported $2.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.21. Bath & Body Works had a net margin of 11.82% and a negative return on equity of 37.01%. The business had revenue of $2.91 billion for the quarter, compared to analyst estimates of $2.84 billion. During the same quarter last year, the business earned $1.86 earnings per share. The company’s revenue for the quarter was up .8% compared to the same quarter last year. Equities research analysts anticipate that Bath & Body Works, Inc. will post 3.3 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 8th. Stockholders of record on Friday, February 23rd were paid a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 1.68%. The ex-dividend date was Thursday, February 22nd. Bath & Body Works’s dividend payout ratio is currently 20.78%.

Analyst Ratings Changes

A number of research firms have recently issued reports on BBWI. The Goldman Sachs Group increased their price objective on shares of Bath & Body Works from $49.00 to $56.00 and gave the company a “buy” rating in a research note on Monday, March 4th. UBS Group increased their target price on shares of Bath & Body Works from $46.00 to $52.00 and gave the company a “neutral” rating in a research report on Monday, March 4th. Wells Fargo & Company increased their target price on shares of Bath & Body Works from $42.00 to $48.00 and gave the company an “equal weight” rating in a research report on Wednesday, April 24th. Robert W. Baird increased their target price on shares of Bath & Body Works from $50.00 to $54.00 and gave the company an “outperform” rating in a research report on Friday, March 1st. Finally, TD Cowen raised their price target on shares of Bath & Body Works from $35.00 to $55.00 and gave the stock an “outperform” rating in a report on Friday, March 1st. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and six have given a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $46.73.

Insider Transactions at Bath & Body Works

In other news, insider Thomas E. Mazurek sold 4,285 shares of the firm’s stock in a transaction dated Wednesday, March 27th. The shares were sold at an average price of $48.89, for a total value of $209,493.65. Following the transaction, the insider now directly owns 45,992 shares of the company’s stock, valued at $2,248,548.88. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.19% of the company’s stock.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.